Literature DB >> 23118217

The triumph of good over evil: protection by the sickle gene against malaria.

H Franklin Bunn1.   

Abstract

The mechanisms underlying Plasmodium falciparum resistance in persons with sickle trait have been under active investigation for more than a half century. This Perspective reviews progress in solving this challenging problem, including recent studies that have exploited the genomics and proteomics of the parasite. The formation of Hb S polymer in the parasitized AS RBC leads to impaired parasite growth and development along with enhanced clearance from the circulation and reduced deposition in deep postcapillary vascular beds. Enhanced generation of reactive oxygen species in sickled AS RBCs is a pathogenetic feature shared by parasitized thalassemic and G6PD-deficient RBCs, triggering abnormal topology of the RBC plasma membrane with decreased and disordered display of PfEMP-1, a P falciparum adhesion protein critical for endothelial adherence. A mouse model of Hb S confers host tolerance to P berghei, through inhibition of pathogenic CD8(+) T cells and induction of heme oxygenase-1. An additional and apparently independent mode of protection is provided by the selective expression in AS RBCs of 2 species of microRNA that integrate into P falciparum mRNAs and inhibit translation and parasite growth.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23118217     DOI: 10.1182/blood-2012-08-449397

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

Review 1.  Environmental determinants of severity in sickle cell disease.

Authors:  Sanjay Tewari; Valentine Brousse; Frédéric B Piel; Stephan Menzel; David C Rees
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

2.  Hemoglobinopathic erythrocytes affect the intraerythrocytic multiplication of Plasmodium falciparum in vitro.

Authors:  Svetlana Glushakova; Amanda Balaban; Philip G McQueen; Rosane Coutinho; Jeffery L Miller; Ralph Nossal; Rick M Fairhurst; Joshua Zimmerberg
Journal:  J Infect Dis       Date:  2014-03-31       Impact factor: 5.226

Review 3.  The genetic theory of infectious diseases: a brief history and selected illustrations.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-05-29       Impact factor: 8.929

4.  Harnessing red cell membrane pathophysiology towards point-of-care diagnosis for sickle cell disease.

Authors:  Seth L Alper
Journal:  J Physiol       Date:  2013-03-15       Impact factor: 5.182

5.  Maturation of Plasmodium falciparum in multiply infected erythrocytes and the potential role in malaria pathogenesis.

Authors:  Augustine U Orjih
Journal:  Parasitol Res       Date:  2014-08-15       Impact factor: 2.289

6.  Prevalence of inherited blood disorders and associations with malaria and anemia in Malawian children.

Authors:  Patrick T McGann; Anne M Williams; Graham Ellis; Kathryn E McElhinney; Laurel Romano; Julia Woodall; Thad A Howard; Gerald Tegha; Robert Krysiak; R Murray Lark; E Louise Ander; Carine Mapango; Kenneth I Ataga; Satish Gopal; Nigel S Key; Russell E Ware; Parminder S Suchdev
Journal:  Blood Adv       Date:  2018-11-13

Review 7.  Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.

Authors:  Venée N Tubman; Julie Makani
Journal:  Br J Haematol       Date:  2017-05-11       Impact factor: 6.998

8.  Priapism in a patient with sickle cell trait using marijuana.

Authors:  Abhishek Matta; Pavan Kumar Tandra; Lyudmyla Berim
Journal:  BMJ Case Rep       Date:  2014-05-05

9.  Perception of young adults with sickle cell disease or sickle cell trait about participation in the CHOICES randomized controlled trial.

Authors:  Patricia E Hershberger; Agatha M Gallo; Robert Molokie; Alexis A Thompson; Marie L Suarez; Yingwei Yao; Diana J Wilkie
Journal:  J Adv Nurs       Date:  2015-06-15       Impact factor: 3.187

10.  THE GORDON WILSON LECTURE: THE ETHICS OF HUMAN GENOME EDITING.

Authors:  Barry S Coller
Journal:  Trans Am Clin Climatol Assoc       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.